| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |